APA

Wijesinghe H., Galappatthy P., de Silva R., Seneviratne S. L., Saravanamuttu U., Udagama P., Hart M., Kelleher P., Senerath U., Fernandopulle R., Weerasekera L. P. & Wijayaratne L. S. (20180417). Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial. : BMC musculoskeletal disorders.

Chicago

Wijesinghe Harindu, Galappatthy Priyadharshini, de Silva Rajiva, Seneviratne Suranjith L, Saravanamuttu Ushagowry, Udagama Preethi, Hart Melanie, Kelleher Peter, Senerath Upul, Fernandopulle Rohini, Weerasekera Lilani P and Wijayaratne Lalith S. 20180417. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial. : BMC musculoskeletal disorders.

Harvard

Wijesinghe H., Galappatthy P., de Silva R., Seneviratne S. L., Saravanamuttu U., Udagama P., Hart M., Kelleher P., Senerath U., Fernandopulle R., Weerasekera L. P. and Wijayaratne L. S. (20180417). Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial. : BMC musculoskeletal disorders.

MLA

Wijesinghe Harindu, Galappatthy Priyadharshini, de Silva Rajiva, Seneviratne Suranjith L, Saravanamuttu Ushagowry, Udagama Preethi, Hart Melanie, Kelleher Peter, Senerath Upul, Fernandopulle Rohini, Weerasekera Lilani P and Wijayaratne Lalith S. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial. : BMC musculoskeletal disorders. 20180417.